Literature DB >> 20656019

Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes.

Hadas Bar-Joseph1, Irit Ben-Aharon, Shulamith Rizel, Salomon M Stemmer, Moran Tzabari, Ruth Shalgi.   

Abstract

Ovarian failure is a-known side-effect observed in women treated for cancer. Doxorubicin (DXR) was found to be detrimental to MII mouse oocytes. We aimed at characterizing the effect of DXR on germinal vesicle (GV) oocytes that comprise the majority of oocytes within ovaries encountering chemotherapy. Mouse follicles and oocytes were exposed to DXR in vitro. DXR localization and its possible cellular targets were examined by fluorescence confocal microscopy. We demonstrated that DXR crosses the blood-follicle barrier and accumulates in oocytes and granulosa cells. The mechanism of DXR-induced apoptosis involves chromosomal disintegration, activation of the mitochondria followed by activation of PERK and caspase-12 and inactivation of PARP. The follicular GV oocytes were more vulnerable to the toxic effect of DXR than ovulated MII oocytes. We suggest that DXR elicits apoptotic signal within GV oocytes that involves activation of the mitochondria, induction of ER-stress and a possible increase in intracellular calcium.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656019     DOI: 10.1016/j.reprotox.2010.07.003

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  25 in total

1.  Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage.

Authors:  Sandrine Lépine; Jeremy C Allegood; Yvette Edmonds; Sheldon Milstien; Sarah Spiegel
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

2.  Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.

Authors:  Maria Mavroudi; Paul Zarogoulidis; Konstantinos Porpodis; Ioannis Kioumis; Sofia Lampaki; Lonny Yarmus; Raf Malecki; Konstantinos Zarogoulidis; Marek Malecki
Journal:  J Cancer Res Ther (Manch)       Date:  2014

Review 3.  Vitrification of embryos and oocytes for fertility preservation in cancer patients.

Authors:  Keiichi Kato
Journal:  Reprod Med Biol       Date:  2016-02-29

4.  Interleukin-1 deficiency prolongs ovarian lifespan in mice.

Authors:  Shiri Uri-Belapolsky; Aviv Shaish; Efrat Eliyahu; Hadas Grossman; Mattan Levi; Dana Chuderland; Lihi Ninio-Many; Noa Hasky; David Shashar; Tal Almog; Michal Kandel-Kfir; Dror Harats; Ruth Shalgi; Yehuda Kamari
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

5.  Multidrug Resistance Protein 1 Deficiency Promotes Doxorubicin-Induced Ovarian Toxicity in Female Mice.

Authors:  Yingzheng Wang; Mingjun Liu; Jiyang Zhang; Yuwen Liu; Megan Kopp; Weiwei Zheng; Shuo Xiao
Journal:  Toxicol Sci       Date:  2018-05-01       Impact factor: 4.849

6.  Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells.

Authors:  Elon C Roti Roti; Sana M Salih
Journal:  Biol Reprod       Date:  2012-03-30       Impact factor: 4.285

7.  Doxorubicin Has Dose-Dependent Toxicity on Mouse Ovarian Follicle Development, Hormone Secretion, and Oocyte Maturation.

Authors:  Shuo Xiao; Jiyang Zhang; Mingjun Liu; Hideyuki Iwahata; Hunter B Rogers; Teresa K Woodruff
Journal:  Toxicol Sci       Date:  2017-06-01       Impact factor: 4.849

8.  Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation.

Authors:  Yingzheng Wang; Mingjun Liu; Sarah B Johnson; Gehui Yuan; Alana K Arriba; Maria E Zubizarreta; Saurabh Chatterjee; Mitzi Nagarkatti; Prakash Nagarkatti; Shuo Xiao
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-19       Impact factor: 4.219

9.  The blood-follicle barrier (BFB) in disease and in ovarian function.

Authors:  Michelle K Y Siu; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

10.  RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.

Authors:  Miao He; Hai-Gang Sun; Jun-Ying Hao; Yan-Lin Li; Jian-Kun Yu; Yuan-Yuan Yan; Lin Zhao; Na Li; Yan Wang; Xue-Feng Bai; Zhao-Jin Yu; Zhi-Hong Zheng; Xiao-Yi Mi; En-Hua Wang; Min-Jie Wei
Journal:  Oncol Rep       Date:  2013-02-21       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.